- Release Date: 06/05/20 10:13
- Summary: First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS
- Price Sensitive: No
- Download Document 128.22KB
-
- There are more pages in this discussion • 129 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.30 |
Change
0.005(0.22%) |
Mkt cap ! $2.918B | |||
| Open | High | Low | Value | Volume |
| $2.26 | $2.31 | $2.25 | $3.066M | 1.342M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 21211 | $2.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.30 | 139566 | 24 |
View Market Depth
| Last trade - 14.53pm 12/08/2025 (20 minute delay) ? |
| MSB (ASX) Chart |